A detailed history of Bridgewealth Advisory Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bridgewealth Advisory Group, LLC holds 10,073 shares of PFE stock, worth $268,143. This represents 0.11% of its overall portfolio holdings.

Number of Shares
10,073
Previous 8,764 14.94%
Holding current value
$268,143
Previous $245 Million 18.89%
% of portfolio
0.11%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $36,259 - $41,089
1,309 Added 14.94%
10,073 $292 Million
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $3,309 - $3,877
-131 Reduced 1.47%
8,764 $245 Million
Q1 2024

Apr 18, 2024

BUY
$25.89 - $29.73 $230,291 - $264,448
8,895 New
8,895 $247 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bridgewealth Advisory Group, LLC Portfolio

Follow Bridgewealth Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewealth Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewealth Advisory Group, LLC with notifications on news.